Leadership

EXECUTIVE TEAM
..........................................................

Eddie J. Sullivan, PhD

PRESIDENT & CEO
CO-FOUNDER
 

Edward Hamilton, DVM

EXECUTIVE CHAIRMAN, BOD
CO-FOUNDER
 

Charles H. Randall, Jr., MBA

EVP & CFO

Rick Finnegan

EVP OF PROGRAM MANAGEMENT

 

Thomas Luke, MD
CHIEF MEDICAL OFFICER


 

Jerry Pommer, MSc

CCO, VP REGULATORY COMPLIANCE
& QUALITY ASSURANCE

 

Melissa Ullerich 

SVP CORPORATE COMMUNICATIONS

 

RESEARCH TEAM
.......................................................... 

Christoph L. Bausch, MBA, PhD 

CHIEF SCIENCE OFFICER


Hua Wu, PhD

SVP VACCINE & ANTIBODY DEVELOPMENT

 

Jin-an Jiao, PhD

ADVISOR & CONSULTANT


SCIENTIFIC ADVISORY BOARD
..........................................................

James Robl, PhD

TECHNOLOGY CO-FOUNDER,
TRANSGENIC ANIMAL EXPERT


Arturo Casadevall, MD, PhD

CHAIRMAN–DEPARTMENT OF MOLECULAR
MICROBIOLOGY & IMMUNOLOGY
Johns Hopkins Bloomberg School of Public Health

 

Michael Haller, MD, MS-CI

PROFESSOR PEDIATRICS, ENDOCRINOLOGY,
TYPE 1 DIABETES RESEARCHER
University of Florida College of Medicine


Frederick Hayden, MD

ADVISOR & PROFESSOR EMERITUS
University of Virginia School of Medicine


BOARD OF DIRECTORS
..........................................................

Edward Hamilton, DVM

CHAIRMAN / CO-FOUNDER

Co-Owner BioDak, LLC


David Link
VICE CHAIRMAN
Retired Executive Vice President,
Sanford Health

 

Eddie J. Sullivan, PhD
PRESIDENT & CEO / CO-FOUNDER
Co-Owner BioDak, LLC


Christine Hamilton
CO-FOUNDER
Managing Partner, Christiansen Land & Cattle
Co-Owner BioDak, LLC

 

 

Thorkil Kastberg Christensen

DIRECTOR
Advisor Novo A/S



William J. Polvino, MD
DIRECTOR
CEO, Bridge Medicines